The sleep of abstinent pure primary alcoholic patients: Natural course and relationship to relapse

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 8, 1998, Pages 1796-1802

  Drummond, Sean P A ^a,b,c   Gillin, J Christian ^a   Smith, Tom L ^a   DeModena, Anna ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Abstinence; Alcoholism; Relapse; Sleep

Indexed keywords

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL FEATURE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SLEEP PATTERN;

EID: 0031762738     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1998.tb03983.x     Document Type: Article

References (26)

1. Gillin JC, Smith TL, Irwin M, Kripke DF, Schuckit M: EEG sleep in "pure" primary alcoholism during subacute withdrawal: Relationships to normal controls, age, and other clinical variables. Biol Psychiatry 27:477-488, 1990
2. Thompson PM, Gillin JC, Golshan S, Irwin M: Polygraphic sleep measures differentiate alcoholics and stimulant abusers during short-term abstinence. Biol Psychiatry 38:831-836, 1995
3. Williams HL, Rundell OH: Altered sleep physiology in chronic alcoholics: Reversal with abstinence. Alcohol Clin Exp Res 2:318-325, 1981
4. Snyder S, Karacan I: Sleep patterns of sober chronic alcoholics. Neuropsychobiology 13:97-100, 1985
5. Le Bon O, Verbanck P, Hoffman G, Murphy JR, Staner L, De Grote D, Mampunza S, Den Dulk A, Vache C, Kornreich Ch, Pelc I: Sleep in detoxified alcoholics: Impairment of most standard sleep parameters and increased risk for sleep apnea, but not myoclonias: A controlled study. J Stud Alcohol 58:30-36, 1997
6. Gillin JC, Smith TL, Irwin M, Butters N, Demodena A, Schuckit M: Increased pressure of rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry 51:189-197, 1994
7. Clark CP, Gillin JC, Golshan S, DeModena A, Smith TL, Danowski S, Irwin M, Schuckit, M: Increased REM sleep density at admission predicts relapse by 3 months in primary alcoholics with a lifetime diagnosis of secondary depression. Biol Psychiatry 43:601-607, 1998
8. Aldrich MS, O'Neal EA, Eiser AS, Kroll P, Brower K, Shipley JE: Slow wave sleep decrement and relapse tendency in alcoholics in treatment. Sleep Res 23:185, 1994
9. Schuckit MA: The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry 42:1043-1049, 1985
10. Irwin M, Baird SM, Smith TL, Schuckit M: Use of laboratory tests to monitor heavy drinking by men discharged from a treatment program. Am J Psychiatry 145:595-599, 1998
11. Recthschaffen A. Kales A: A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep States of Human Subjects. Washington, D.C., U.S. Public Health Service, 1968
12. Maxwell SE, Delany HD: Designing Experiments and Analyzing Data: A Model Comparison Perspective. Belmont, Wadsworth Publishing Company, 1990
13. Bano S, Orerri R, Morgan CJ, Badawy AA, Buckland PR, McGuffin P: Effects of chronic administration and subsequent withdrawal of ethanol-containing liquid diet on rat liver tryptophan pyrrolase and tryptophan metabolism. Alcohol Alcohol 31:205-215, 1996
14. Badawy AA, Morgan CJ, Thomas R: Tryptophan and 5-hydroxytryptamine metabolism in alcoholism. Alcohol Alcohol 26 (Suppl 2):231-235, 1993
15. Bhatti T, Gillin JC, Seifritz E, Moore P, Clark C, Golshan S, Stahl S, Rapaport M, Kelsoe J: Effects of tryptophan-free amino acid drink challenge on normal human sleep and mood. Biol Psychiatry 43:52-59, 1998
16. Moore P, Drummond S, Seifritz E, Bhatti T, Gillin JC: Sleep and dreams, in Michels R, Cooper AM, Guze SB, Judd LJ, Solnit AJ, Stunkard AJ, Weissman MM (eds): Psychiatry, vol 3, chap 60. Philadelphia, Lippincott-Raven, 1997, pp 1-20
17. Dietzel M, Sepandj P, Pichler R, Frey B, Saletu StR: Sleep quality and architecture during alcohol withdrawal. Sleep Res 24A:295, 1995
18. Schuckit MA Recent developments in the pharmacotherapy of alcohol dependence. JCCP 64:669-676, 1996
19. Lejoyeux M: Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism. Alcohol Alcohol 31(Suppl 1):69-75, 1996
20. Kupfer DJ, Perel JM, Pollock BG, Nathan RS, Grochocinski VJ, Wilson MJ, McEachran AB: Fluvoxamine versus desipramine: Comparative polysomnographic effects. Biol Psychiatry 29:23-40, 1991
21. Dorsey CM, Lukas SE, Cunningham SL: Fluoxetine-induced sleep disturbances in depressed patients. Neuropsychopharmacology 14:437-442, 1996
22. Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ: A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: A double-blind, 8-week clinical trial. J Clin Psychiatry 58:185-192; 1997
23. Nicholson AN, Pascoe PA: Studies on the modulation of sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor. Neuropharmacology 27:597-602, 1988
24. Oswald I, Adam K: Effects of paroxetine on human sleep. Br J Clin Pharmacol 22:97-99, 1986
25. Bootzin RR, Rider SP: Behavioral techniques and biofeedback for insomnia, in: Pressman MR, Orr WC (eds): Understanding Sleep: The Evaluation and Treatment of Sleep Disorders. Washington, D.C., American Psychological Association, 1997, pp 315-338
26. Yoshino A, Kato M, Yoshimasu H, Tatsuzawa Y, Watanabe T: Which relapse criteria best predict the mortality risk of treated alcoholics? Alcohol Clin Exp Res 21:1374-1378, 1997